Your browser doesn't support javascript.
loading
Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma.
Levenson, Cathy W; Morgan, Thomas J; Twigg, Pamela D; Logan, Timothy M; Schepkin, Victor D.
Affiliation
  • Levenson CW; Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA.
  • Morgan TJ; Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
  • Twigg PD; Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA.
  • Logan TM; Department of Chemistry and Biochemistry and Institute for Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
  • Schepkin VD; Current Address: Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA.
Cancer Drug Resist ; 2(3): 862-876, 2019.
Article in En | MEDLINE | ID: mdl-35582585